HIV & AIDS

Costs of ART regimens increasing, outpacing inflation

(HealthDay)—Initial regimens recommended for most people with HIV (PWH) are priced above $36,000 per year, with antiretroviral therapy (ART) cost increases exceeding the inflation rate, according to a research letter published ...

HIV & AIDS

Does timing matter for initiating HIV therapy in infants?

Starting HIV antiretroviral therapy (ART) within hours of birth has been hypothesized to have positive effects raising the possibility of remission in some children with HIV. To test the hypothesis, researchers at Columbia ...

HIV & AIDS

Single dose of antibodies can knock out HIV in newborns

A single dose of an antibody-based treatment can prevent HIV transmission from mother to baby, new nonhuman primate research suggests for the first time. The findings are being published in the journal Nature Communications.

HIV & AIDS

Nurses can help manage drug interactions in HIV/Hep C treatment

(HealthDay)—Drug interactions between antiretroviral therapy (ART) and direct-acting antivirals (DAAs) pose a clinical challenge in patients with HIV/hepatitis C virus (HCV) coinfection, according to an article published ...

page 19 from 40